Guangdong VTR Bio-Tech Co., Ltd., a biotechnology company, researches, develops, produces, and sells bio-enzyme preparations, biosynthetic products, and plant e...
CEC Capital advises Zhongkexinyang on 100-million-yuan private financing round
VTR released its performance for the first three quarters, with a net profit attributable to the parent company of 18.2044 million yuan, a decrease of 57.47%
VTR: The company has currently stopped the production of Vitamin B12
HAID GROUP, VTR and other newly established biotechnology companies
VTR: Net profit of 13.997 million yuan in the first half of 2025, a year-on-year decrease of 66.50%
VTR released its first-quarter results, with a net profit attributable to the parent company of 4.8705 million yuan, a year-on-year decrease of 75.19%